Pharmacogenetics of osteoporosis-related bone fractures: moving towards the harmonization and validation of polymorphism diagnostic tools

Author： Venegas Karen Rojo   Gómez Margarita Aguilera   Eisman John Allan   Sánchez Antonio García   Dader María J Faus   Hernández Miguel A Calleja  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.11, Iss.9, 2010-09, pp. : 1287-1303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Long-term PPI use increases osteoporosis-related fracture risk

By  

Reactions Weekly, Vol. 1, Iss. 1218, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Long-term PPI use increases osteoporosis-related fracture risk

By  

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

The future of pharmacogenetics for osteoporosis

By Marini Francesca   Brandi Maria Luisa  

Pharmacogenomics, Vol. 14, Iss. 6, 2013-04 ,pp. : 641-653

Future Medicine

Access to resources Recommend Favorite

Effects of Statins on Bone Markers, Bone Mineral Density and Fractures. Possible Role in Osteoporosis Treatment

By  

Current Pharmaceutical Analysis, Vol. 2, Iss. 2, 2006-05 ,pp. : 161-168

Bentham Science Publishers

Access to resources Recommend Favorite

Bone Physiology, Disease and Treatment: Towards Disease System Analysis in Osteoporosis

By Post Teun M.  

Clinical Pharmacokinetics, Vol. 49, Iss. 2, 2010-02 ,pp. : 89-118

Adis International

Access to resources Recommend Favorite